These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 751451)

  • 21. [Symposium--drug metabolism and drug action. 6. Duration of sleep induced by hexobarbital following thyroidectomy hexobarbital metabolism].
    Tochino Y; Matsubarat ; Takase H
    Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):85-6. PubMed ID: 5531425
    [No Abstract]   [Full Text] [Related]  

  • 22. Hexobarbital sleeping time in male rats with hepatic injury.
    Varga F; Fischer E
    Acta Physiol Acad Sci Hung; 1969; 36(4):431-9. PubMed ID: 5376036
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in the hexobarbital sleep and serum cholinesterase activity of rats treated with carbaryl].
    Dobreva V; Kaloianova F
    Probl Khig; 1988; 13():109-14. PubMed ID: 3149406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 25. Imipramine induced potentiation of hexobarbitone hypnosis in rat: role of serotonin.
    Bhattacharya SK
    Indian J Exp Biol; 1978 Mar; 16(3):362-3. PubMed ID: 680837
    [No Abstract]   [Full Text] [Related]  

  • 26. The potentiation of barbiturate-induced narcosis by procarbazine.
    Lee IP; Lucier GW
    J Pharmacol Exp Ther; 1976 Mar; 196(3):586-93. PubMed ID: 1263114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 28. Synergistic effect of prostaglandin E1 and disulfiram on the prolongation of hexobarbital hypnosis.
    Fukumori R; Minegishi A; Satoh T; Kitagawa H; Yanaura S
    Brain Res; 1980 Jan; 181(1):241-4. PubMed ID: 7350961
    [No Abstract]   [Full Text] [Related]  

  • 29. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 30. In-vivo and in-vitro studies of the effects of mercaptoundecahydrododecaborate (BSH) on hepatic cytochrome P-450 mono-oxygenase enzyme activity and on hexobarbital (HXB) induced sleep in mice.
    Fontenelle L; Garner G; Graham B; Goettsch R; Soltani B
    Strahlenther Onkol; 1989; 165(2-3):172-3. PubMed ID: 2928942
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of subchronic treatment with (-) 8 -trans-tetrahydrocannabinol ( 8 -THC) on food intake, body temperature, hexobarbital sleeping time and hexobarbital elimination in rats.
    Rating D; Broermann I; Honecker H; Kluwe S; Coper H
    Psychopharmacologia; 1972; 27(4):349-57. PubMed ID: 4648618
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of some antibiotics on hexobarbitone sleeping time in rats.
    Phansalkar AG; Balwani JH
    Hindustan Antibiot Bull; 1970 May; 12(4):179-80. PubMed ID: 5469705
    [No Abstract]   [Full Text] [Related]  

  • 33. Increase of hexobarbital sleeping time and inhibition of drug metabolism by the major metabolite of diphenylhydantoin.
    Stavchansky SA; Lubawy WC; Kostenbauder HB
    Life Sci; 1974 Apr; 14(8):1535-9. PubMed ID: 4829543
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of propranolol, pindolol and atenolol after multiple administration in rats on the duration of hexobarbital sleeping time and on the activity of some drug-metabolizing enzyme systems.
    Kastelova A; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1993; 19(4):101-4. PubMed ID: 8203279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance development to cadmium-induced alteration of drug action.
    Roberts SA; Miya TS; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):197-200. PubMed ID: 935651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Dopram(R) and its effects on hexobarbital narcosis.
    Flint BA; Ho IK
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):271-9. PubMed ID: 694225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of hypersensitivity of brain by hydralazine treatment in rats.
    Hara S; Satoh T; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):251-7. PubMed ID: 7221180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disulfiram impairment of drug metabolism by rat liver microsomes.
    Stripp B; Greene FE; Gillette JR
    J Pharmacol Exp Ther; 1969 Dec; 170(2):347-54. PubMed ID: 4391007
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of serotonin on brain metabolism.
    Mahler DJ; Humoller FL
    Int J Neuropsychiatry; 1967 Jun; 3(3):229-33. PubMed ID: 5298679
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of hepatic drug metabolism by cyclic 3',5'-adenosine monophosphate.
    Weiner M; Buterbaugh GG; Blake DA
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):249-63. PubMed ID: 4372659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.